In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts [Corrigendum]

by Sreeranganathan M, Uthaman S, Sarmento B, Mohan CG, Park IK, Jayakumar R
Published 2019-06-01

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts

by Sreeranganathan M, Uthaman S, Sarmento B, Mohan CG, Park IK, Jayakumar R
Published 2017-09-01